The use of blood flow modifiers to improve the treatment response of solid tumors
Author:
Publisher
Elsevier BV
Subject
Radiology, Nuclear Medicine and imaging,Oncology,Hematology
Reference33 articles.
1. Potentiation of RSU-1069 tumour cytotoxicity by 5-hydroxytryptamine (5-HT);Chaplin;Br. J. Cancer,1986
2. The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: Evidence for therapeutic gain;Chaplin;Int. J. Radiat. Oncol. Biol. Phys.,1987
3. Potentiation of the tumor cytotoxicity of melphalan by vasodilating drugs;Chaplin;Int. J. Radiat. Oncol. Biol. Phys.,1989
4. Acute hypoxia in tumours: implications for modifiers of radiation effects;Chaplin;Int. J. Radiat. Oncol. Biol. Phys.,1986
5. The rheological effects of cinnarizine and flunarizine in normal and pathological conditions;Decree;Angiology,1979
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Biological Basis of Radiation Oncology;Clinical Radiation Oncology;2016
2. Biologic Basis of Radiation Oncology;Clinical Radiation Oncology;2012
3. ABT-751, a novel tubulin-binding agent, decreases tumor perfusion and disrupts tumor vasculature;Anti-Cancer Drugs;2009-07
4. Characterizing the Tumor Response to Treatment With Combretastatin A4 Phosphate;International Journal of Radiation Oncology*Biology*Physics;2007-05
5. Effect of vasodilator hydralazine on tumor microvascular random flow and blood volume as measured by intravoxel incoherent motion (IVIM) weighted MRI in conjunction with Gd-DTPA-Albumin enhanced MRI;Magnetic Resonance Imaging;2001-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3